Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thermo Fisher adds Affinity to protein research offering

This article was originally published in Clinica

Executive Summary

Laboratory equipment manufacturer Thermo Fisher Scientific has purchased antibody provider Affinity BioReagents in a move that increases its antibody offering and complements its protein research capabilities. Waltham, Massachusetts-based Thermo Fisher paid an undisclosed amount to secure Affinity, which will be integrated into the firm’s analytical technologies business. According to Thermo Fisher CEO Marijn Dekkers, this acquisition will allow the company to create end-to-end solutions for protein research applications such as Western blotting, ELISA, immunohistochemistry, flow cytometry and mass spectroscopy. Affinity (Golden, Colorado) recorded revenues of $6m for fiscal 2007 and claims to own more than 35,000 reagents.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel